Treatise: Clinical Practice

Application and imaging characteristics of transrectal real-time tissue elastography combined with MRI in the diagnosis of benign and malignant prostate lesions

  • Kai LI ,
  • Xing WANG ,
  • Zhijun ZENG ,
  • Xu CHENG ,
  • Bo SHI
Expand
  • 1.1Department of Ultrasound Medicine,the Second Affiliated Hospital of Chengdu Medical College (China National Nuclear Corporation 4, Hospital),Chengdu 610051,Sichuan,China2Department of Urology,the Second Affiliated Hospital of Chengdu Medical College (China National Nuclear Corporation 4, Chengdu 610051,Sichuan,China
    2.1Department of Ultrasound Medicine,the Second Affiliated Hospital of Chengdu Medical College (China National Nuclear Corporation 4, Hospital), Chengdu 610051,Sichuan,China

Received date: 2025-11-11

  Revised date: 2025-12-26

  Accepted date: 2025-12-31

  Online published: 2026-03-26

Abstract

Objective To explore the application and imaging characteristics of transrectal real-time tissue elastography (TRTE) combined with magnetic resonance imaging (MRI) in the diagnosis of benign and malignant prostate lesions. Methods A total of 154 patients with suspected prostate cancer were collected and received TRTE and MRI. The imaging characteristics were analyzed, and the diagnostic value of TRTE and MRI on benign and malignant prostate lesions was evaluated with the pathological result of needle biopsy as the gold standard. Results Among the 154 patients, 79 malignant cases (prostate cancer, 51.30%) and 75 benign cases (benign prostatic hyperplasia, 48.70%) were pathologically diagnosed by needle biopsy. The malignant prostate lesions in the TRTE image were mainly manifested as lesions with a predominantly blue core (high stiffness, low strain), often with green margins or transitions (moderate strain, moderate stiffness). In MRI images, the lesions primarily exhibited low signal intensity on T2WI, high signal intensity on DWI, and low signal intensity on ADC, and early and obvious enhancement on DCE. Compared with patients with benign lesions, those with malignant lesions exhibited significantly older age and higher mean biopsy frequency, total prostate specific antigen (tPSA), prostate-specific antigen density (PSAD), SR scores and PI-RADS score (P < 0.05). Compared with clinicopathological diagnosis (gold standard), the diagnostic efficiency of TRTE and MRI based on binary classification showed no statistically significant difference in distinguishing benign from malignant prostate lesions (P > 0.05). Multivariate logistic regression analysis revealed that after adjusting for age and PSAD, TRTE elasticity score and MRI PI-RADS score were predictive factors for prostate malignancy (P < 0.05). Consequently, a prostate malignancy risk model was constructed as logit(P) = -0.421 + 0.072 × age + 0.087 × PSAD + 0.181 × elasticity score + 0.358 × PI-RADS V2.1 score. Taking the pathological diagnosis result as the gold standard, the sensitivities of TRTE, MRI and logistic regression model constructed by TRTE combined with MRI in the diagnosis of benign and malignant prostate lesions were 81.01%, 84.81% and 94.94%, and the specificities were 88.00%, 82.67% and 85.33%. The logistic regression model constructed by TRTE combined with MRI had the best diagnostic efficiency (area under the curve of 0,933). Conclusions The TRTE signs of lesions with a predominantly blue core and the MRI signs of T2WI low signal, DWI high signal, ADC low signal, DCE “fast in and fast out” enhancement are helpful to the diagnosis of benign and malignant prostate lesions. TRTE combined with MRI is helpful to enhance the diagnostic efficiency.

Cite this article

Kai LI , Xing WANG , Zhijun ZENG , Xu CHENG , Bo SHI . Application and imaging characteristics of transrectal real-time tissue elastography combined with MRI in the diagnosis of benign and malignant prostate lesions[J]. The Journal of Practical Medicine, 2026 , 42(6) : 1070 -1077 . DOI: 10.3969/j.issn.1006-5725.2026.06.021

References

[1] YU X D, YAN S S, LIU R J, et al. Apparent differences in prostate zones: Susceptibility to prostate cancer, benign prostatic hyperplasia and prostatitis[J]. Int Urol Nephrol, 2024, 56(8): 2451-2458. doi:10.1007/s11255-024-04012-w .
[2] 王芸, 李萍, 陈璐, 等. 以IKAP理论为指导的延续性护理对老年前列腺癌术后患者尿失禁及生活质量的影响[J]. 护理实践与研究, 2024, 21(1): 125-131. doi:10.3969/j.issn.1672-9676.2024.01.019 .
[3] DESTOUNI M, LAZARIS A C, TZELEPI V. Cribriform patterned lesions in the prostate gland with emphasis on differential diagnosis and clinical significance[J]. Cancers, 2022, 14(13): 3041. doi:10.3390/cancers14133041 .
[4] 胡博文, 胡亚兰, 梁辉. 前列腺癌早期筛查的常见方法及最新研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(6): 800-808. doi:10.3877/cma.j.issn.1674-3253.2025.06.019 .
[5] WANG Y, FENG Y, YANG X, et al. Enhanced transrectal ultrasound, real-time sonoelastography, and contrast-enhanced transrectal ultrasound in heavily prescreened Chinese men with naive and repetitive biopsy: A comparison of detection rate of prostate cancer per man and per lesion[J]. Ultrasound Q, 2022, 38(3): 237-245. doi:10.1097/RUQ.0000000000000589 .
[6] FERNANDES M C, YILDIRIM O, WOO S, et al. The role of MRI in prostate cancer: Current and future directions[J]. MAGMA, 2022, 35(4): 503-521. doi:10.1007/s10334-022-01006-6 .
[7] KAMOI K, OKIHARA K, OCHIAI A, et al. The utility of transrectal real-time elastography in the diagnosis of prostate cancer[J]. Ultrasound Med Biol, 2008, 34(7): 1025-1032. doi:10.1016/j.ultrasmedbio.2007.12.002 .
[8] TURKBEY B, ROSENKRANTZ A B, HAIDER M A, et al. Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2[J]. Eur Urol, 2019, 76(3): 340-351. doi:10.1016/j.eururo.2019.02.033 .
[9] WILLIAMS I S, MCVEY A, PERERA S, et al. Modern paradigms for prostate cancer detection and management[J]. Med J Aust, 2022, 217(8): 424-433. doi:10.5694/mja2.51722 .
[10] GOURDIN T, VELAYATI A. Treatments and challenges in advanced prostate cancer[J]. Curr Opin Oncol, 2023, 35(3): 200-205. doi:10.1097/CCO.0000000000000938 .
[11] IPPOLITI S, FLETCHER P, ORECCHIA L, et al. Optimal biopsy approach for detection of clinically significant prostate cancer[J]. Br J Radiol, 2022, 95(1131): 20210413. doi:10.1259/bjr.20210413 .
[12] 张继燊, 谢玉洁, 杨婷, 等. 前列腺特异性膜抗原PET/CT对减少前列腺癌过度穿刺活检的应用价值[J]. 中山大学学报(医学科学版), 2025, 46(2): 311-317. doi:10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2025.0215 .
[13] 沈波, 李安域, 朱正, 等. 磁共振/超声成像融合引导的经会阴前列腺穿刺活检对前列腺癌的诊断价值[J]. 转化医学杂志, 2024, 13(10): 1712-1717. doi:10.3639/i.issn.2095-3097. 2024.10.034 .
[14] INOUE T, SHIN T. Current magnetic resonance imaging-based diagnostic strategies for prostate cancer[J]. Int J Urol, 2023, 30(12): 1078-1086. doi:10.1111/iju.15281 .
[15] LIU Y, ZENG S, ZHOU D, et al. Diagnostic performance of multiple ultrasonic modalities for prostate cancer[J]. Clinics, 2025, 80: 100680. doi:10.1016/j.clinsp.2025.100680 .
[16] ALMALKI Y E, MANSOUR M G E, ALI S A, et al. Advanced strain elastography is a reliable approach for prostate cancer detection in patients with elevated PSA levels[J]. Sci Rep, 2024, 14: 2917. doi:10.1038/s41598-024-53440-2 .
[17] LI J, ZHU C, YANG S, et al. Non-invasive diagnosis of prostate cancer and high-grade prostate cancer using multiparametric ultrasonography and serological examination[J]. Ultrasound Med Biol, 2024, 50(4): 600-609. doi:10.1016/j.ultrasmedbio. 2024. 01.003 .
[18] 杨秋子, 毛星刚, 孙季冬, 等. 头颅磁共振成像在轻型颅脑损伤诊断与预后评估中的应用进展[J]. 中华神经外科疾病研究杂志, 2024, 18(6): 90-94.
[19] FIARD G, GIGANTI F. How MRI is changing prostate cancer management: A focus on early detection and active surveillance: Comment l’IRM est en train de révolutionner la prise en charge du cancer de la prostate: Focus sur la détection précoce et la surveillance active[J]. Prog Urol, 2022, 32(6S1): 6S19-6S25. doi:10.1016/S1166-7087(22)00171-3 .
[20] 刘玉姗, 徐冉, 曾施, 等. 多种超声模式在前列腺癌诊断中的应用价值比较[J]. 中国临床医学影像杂志, 2023, 34(4): 250-254. doi:10.12117/jccmi.2023.04.006 .
[21] NG A B C D, ASIF A, AGARWAL R, et al. Biparametric vs multiparametric MRI for prostate cancer diagnosis: The PRIME diagnostic clinical trial[J]. JAMA, 2025, 334(13): 1170-1179. doi:10.1001/jama.2025.13722 .
[22] GREY A D R, SCOTT R, SHAH B, et al. Multiparametric ultrasound versus multiparametric MRI to diagnose prostate cancer (CADMUS): A prospective, multicentre, paired-cohort, confirmatory study[J]. Lancet Oncol, 2022, 23(3): 428-438. doi:10.1016/S1470-2045(22)00016-X .
[23] 张同莉, 王长春, 祖拜热·依斯坎代尔, 等. 经直肠超声造影联合MRI在PSA灰区前列腺癌诊断中的价值[J]. 中国超声医学杂志, 2024, 40(8): 924-927. doi:10.3969/j.issn.1002-0101. 2024.08.027 .
[24] DARYANANI A, TURKBEY B. Recent advancements in CT and MR imaging of prostate cancer[J]. Semin Nucl Med, 2022, 52(3): 365-373. doi:10.1053/j.semnuclmed.2021.11.013 .
[25] DITONNO F, FRANCO A, MANFREDI C, et al. Novel non-MRI imaging techniques for primary diagnosis of prostate cancer: Micro-ultrasound, contrast-enhanced ultrasound, elastography, multiparametric ultrasound, and PSMA PET/CT[J]. Prostate Cancer Prostatic Dis, 2024, 27(1): 29-36. doi:10.1038/s41391-023-00708-9 .
[26] 郭艳娜, 朱益麟, 张萌迪. 经直肠实时组织弹性成像、MRI联合检查参数预测前列腺恶性病变列线图模型的构建及验证[J]. 癌症进展, 2025, 23(17): 2096-2101. doi:10.11877/j.issn.1672-1535.2025.23.17.26 .
[27] SINGH D, CHANDRAN A, PANEBIANCO V, et al. MRI capacity assessment for prostate cancer screening in five sites of Europe[J]. Eur J Radiol, 2025, 190: 112235. doi:10.1016/j.ejrad. 2025.112235 .
Outlines

/